Generic Avodart Now Available

Article

A generic version of Avodart, used to treat the symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate, has been launched by Teva Pharmaceutical Industries Ltd.

A generic version of Avodart, used to treat the symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate, has been launched by Teva Pharmaceutical Industries Ltd.

Teva’s dutasteride capsules, equivalent to GlaxoSmithKline’s Avodart 0.5 mg, lower the production of dihydrotestosterone, thereby relieving symptoms of BPH.

In addition to improving symptoms, dutasteride capsules can reduce the risk of acute urinary retention and reduce the risk of the need for BPH-related surgery.

The capsules are not indicated for the reduction of prostate cancer risk.

Adverse effects of dutasteride include impotence, decreased libido, ejaculation disorders, and breast disorders. The drug may also increase the risk of high-grade prostate cancer.

Patients who take dutasteride should not donate blood until 6 months after they have stopped using the medication.

Related Videos
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.